… The long-acting β2-adrenergic receptor (β2-AR) agonist … Recently, super long-acting β2-AR
agonists vilanterol and … of these super long-acting agonists on the inflammatory response of …

… β 3 -Adrenoceptor agonists were originally considered as a promising drug class for the …
Based on the example of the β 3 -adrenoceptor agonist mirabegron, but also taking into …

… agonist for the β 2 adrenergic receptor (β 2 AR) and the first long-acting β 2 AR agonist to …
, we obtained the crystal structure of salmeterol-bound β 2 AR in complex with an active-state-…

… asthma patients will likely become the future standard. … or paired with a long-acting beta 2
agonist (LABA) for maintenance … This paper reviews the current literature and ongoing studies …

… (HFmrEF) since no substantial prospective randomized clinical trial has been performed
exclusively in such population. According to the recent 2021 European Society of Cardiology (…

… the current evidence concerning the role of adrenergic receptor desensitization and
downregulation in the acute care setting and discuss potential implications for therapy and future …

… It also has a direct vasodilating effect on the blood vessels, which can be related to the
agonistic effect on β 2adrenoceptors located in the vessels. The strongest betablocking effect is …

… present study, and the uncovered mechanism that carvedilol exerts its positive signalling
through β 2 … Notwithstanding these caveats, our new knowledge adds value to the future use of …

… The β2-adrenergic receptor (β2AR), a prototype of the G protein-coupled receptor (GPCR) …
rapid bronchodilation and is therefore the current gold standard for therapeutic treatment of …

… fingerprint of the β 2 -adrenergic receptor (β 2 AR). β-adrenoceptors belong to rhodopsin-like …
& Matera, MG beta(2) -adrenoceptor agonists: current and future direction. British journal of …